Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study
- PMID: 32467245
- DOI: 10.1136/annrheumdis-2020-217903
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study
Keywords: autoimmune diseases; biological therapy; epidemiology.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al.Ann Rheum Dis. 2021 Jun;80(6):e96. doi: 10.1136/annrheumdis-2020-218364. Epub 2020 Jul 6. Ann Rheum Dis. 2021. PMID: 32632030 No abstract available.
-
COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study.Ann Rheum Dis. 2021 Jun;80(6):e95. doi: 10.1136/annrheumdis-2020-218341. Epub 2020 Jul 6. Ann Rheum Dis. 2021. PMID: 32632034 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources